Holen Sie sich die Stockscreener-App
25.36
1.16%
0.29
Handel nachbörslich:
25.36
Alamar Biosciences Inc Aktie (ALMR) Neueste Nachrichten
Alamar Biosciences Inc. (ALMR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Alamar Biosciences, Inc. Revenue Breakdown – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history - Yahoo Finance Australia
Alamar Biosciences, Inc. (ALMR) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease - Yahoo Finance
Alamar Biosciences, Inc. (ALMR) Price Book Value - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
Alamar Biosciences (NASDAQ: ALMR) adjusts board after director death - Stock Titan
This company just filed for an IPO three months after its parent company went public - The Business Journals
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 - The Manila Times
Alamar Biosciences Sets Aug. 10 Results Webcast; Replay to Follow - Stock Titan
IPOs juice biotech real estate (if only a little), but vacancy still climbs and lease rates tumble - The Business Journals
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases - Indovizka.com
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究 - GlobeNewswire Inc.
BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27 - Moomoo
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $30.6, Implies 8% Upside - TradingView
21,000 blood samples to fuel open Alzheimer’s biomarker and AI project - Stock Titan
Alamar Biosciences Launches National-Scale ADRD Proteomics Initiative for Open Biomarker Discovery - Quiver Quantitative
Alamar Biosciences Partners with Leading Research - GlobeNewswire
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling - riauone.com
Alamar’s platform to feature in 140+ presentations at AAIC - Investing.com India
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling - Koreabizwire
Alamar Biosciences to Present NULISA Alzheimer’s Data in More Than 140 AAIC Posters and Sessions - Quiver Quantitative
Alamar Biosciences NULISA Data Featured in More Than 140 - GlobeNewswire
Form 13D/A Alamar Biosciences For: 7 July By Investing.com - Investing.com Nigeria
Sands Capital reports 6.1% Alamar Biosciences (ALMR) stake and board change - Stock Titan
Price to book forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research - Koreabizwire
Alamar Biosciences Launches First Commercial Blood-Based eMTBR-Tau Assay for Alzheimer’s Disease - Quiver Quantitative
Price to sales forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Sherpa Funds Hold 7.2% of Alamar Biosciences (NASDAQ: ALMR) - Stock Titan
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Index - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Value Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000E Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS:ALMR) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Alamar Biosciences Inc (ALMR:UW): Stock Price, Quote and News - BNN Bloomberg
Alamar Biosciences, Inc. (ALMR) Earnings Yield (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to S&P TMI Index - marketscreener.com
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics - Koreabizwire
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):